Feeds

Intel bets millions on speedy DNA sequencing chips

Bio-silicon start-up gets $100m

Gartner critical capabilities for enterprise endpoint backup

Intel is among several investors pumping $100m into a biotech start-up that wants to make mapping an individual's genome as routine as taking an X-ray.

Pacific Biosciences of Menlo Park, California anticipates that by 2013 it will be able to sell a DNA sequencer that can tackle a person's entire hereditary information in as little as 15 minutes. The company's technology centers on the SMRT (Single-Molecule, Real-Time) chip, which is DNA sequencing hardware. Interestingly, companies making DNA sequencing machines have been following a Moore's Law type of trajectory where they're reducing both the time and cost associated with cranking through genomes by about half every 18 months.

The technology departs from the current industry-standard Sanger method of gene inspection — used for the Human Genome Project, which took approximately 13 years to complete. PacBio uses a faster machine that inspects longer blocks of DNA sequences. Long reads make it easier to piece together lengthy, repetitive sequences of complex genomes and generate better overlap to reconstruct them.

PacBio's approach is basically to break double-stranded DNA molecules into single fragment strands that are placed in thousands of 70 nanometer-wide holes on top of sequencing chips.

Normally, DNA replicates itself via enzymes called DNA polymerase. When DNA unzips itself, polymerase duplicates the complementary half, and presto, identical cousins. PacBio feeds in nucleotides with fluorescent markers to suss out what's happening in this process.

According to The Wall Street Journal, PacBio's fistfuls of venture money are being provided by Intel Capital (the investment wing of Intel), Deerfield Capital Management, T. Rowe Price, Morgan Stanley, FMR, Alliance Bernstein Holding, Maverick Capital, Redmile Group, Alloy Ventures, DAG Ventures, TEachers' Private Capital, Kleiner Perkins Caufield & Byers, and Mohr Davidow Ventures.

The Journal reports PacBio hopes hospitals will routinely use the technology to identify how people will respond to drugs based on specific genetic markers.

There's also no better way to show your significant other you care than firming up the odds of her getting cancer. ®

Boost IT visibility and business value

More from The Register

next story
Apple takes blade to 13-inch MacBook Pro with Retina display
Shaves price, not screen on mid-2014 model
iPhone 6 flip tip slips in Aussie's clip: Apple's 'reversible USB' leaks
New plug not compatible with official Type-C, according to fresh rumors
FEAST YOUR EYES: Samsung's Galaxy Alpha has an 'entirely new appearance'
Wow, it looks like nothing else on the market, for sure
YES YES YES! Apple patents mousy, pressure-sensing iVibrator
Fanbois prepare to experience the great Cupertin-O
Steve Jobs had BETTER BALLS than Atari, says Apple mouse designer
Xerox? Pff, not even in the same league as His Jobsiness
TV transport tech, part 1: From server to sofa at the touch of a button
You won't believe how much goes into today's telly tech
Apple analyst: fruity firm set to shift 75 million iPhones
We'll have some of whatever he's having please
Things are looking up in Flappy Bird sequel
'Swing Copters' offers the same gameplay but in a different direction
prev story

Whitepapers

5 things you didn’t know about cloud backup
IT departments are embracing cloud backup, but there’s a lot you need to know before choosing a service provider. Learn all the critical things you need to know.
Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Build a business case: developing custom apps
Learn how to maximize the value of custom applications by accelerating and simplifying their development.
Rethinking backup and recovery in the modern data center
Combining intelligence, operational analytics, and automation to enable efficient, data-driven IT organizations using the HP ABR approach.
Next gen security for virtualised datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.